Lixte Biotechnology Holdings, I (LIXTW) Financials

LIXTW Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 4.3 million 313858
Sept. 30, 2023 5.2 million 311736
June 30, 2023 3.1 million 402614
March 31, 2023 4.3 million 249987

LIXTW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -902123 104057
Sept. 30, 2023 -944389 112106
June 30, 2023 -1.2 million 280060
March 31, 2023 -1.3 million 276980

LIXTW Net Income

No data available :(

LIXTW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 - - -
Sept. 30, 2023 5.1 million - -
June 30, 2023 2.9 million - -
March 31, 2023 4.1 million - -

LIXTW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 2.2 million
Sept. 30, 2023 2.1 million
June 30, 2023 1.7 million
March 31, 2023 1.7 million

LIXTW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 149071 876839 -
Sept. 30, 2023 - 132487 534013 -
June 30, 2023 - 427457 862571 -
March 31, 2023 - 189085 1.2 million -

LIXTW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - -
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - -

LIXTW

Price: $0.05

52 week price:
0.02
0.11

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1400

Market Capitalization: 71534

Links: